AXOGEN INC (AXGN) Stock Fundamental Analysis
USA - NASDAQ:AXGN - US05463X1063 - Common Stock
17.92 USD
-0.25 (-1.38%)
We assign a fundamental rating of 5 out of 10 to AXGN. AXGN was compared to 189 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of AXGN get a neutral evaluation. Nothing too spectacular is happening here. AXGN is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
AXGN had positive earnings in the past year.
AXGN had a positive operating cash flow in the past year.
AXGN had negative earnings in each of the past 5 years.
AXGN had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
With a decent Return On Assets value of -2.27%, AXGN is doing good in the industry, outperforming 68.25% of the companies in the same industry.
AXGN has a Return On Equity of -4.15%. This is in the better half of the industry: AXGN outperforms 69.84% of its industry peers.
The Return On Invested Capital of AXGN (0.75%) is better than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.27% | ||
| ROE | -4.15% | ||
| ROIC | 0.75% |
ROA(3y)-10.24%
ROA(5y)-11.1%
ROE(3y)-20.3%
ROE(5y)-20.84%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a decent Operating Margin value of 0.84%, AXGN is doing good in the industry, outperforming 66.14% of the companies in the same industry.
The Gross Margin of AXGN (74.27%) is better than 85.71% of its industry peers.
AXGN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.84% | ||
| PM (TTM) | N/A | ||
| GM | 74.27% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.72%
GM growth 5Y-1.5%
2. Health
2.1 Basic Checks
AXGN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, AXGN has more shares outstanding
Compared to 5 years ago, AXGN has more shares outstanding
The debt/assets ratio for AXGN has been reduced compared to a year ago.
2.2 Solvency
AXGN has an Altman-Z score of 4.85. This indicates that AXGN is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of AXGN (4.85) is better than 77.78% of its industry peers.
AXGN has a debt to FCF ratio of 13.85. This is a negative value and a sign of low solvency as AXGN would need 13.85 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 13.85, AXGN is in the better half of the industry, outperforming 71.96% of the companies in the same industry.
A Debt/Equity ratio of 0.43 indicates that AXGN is not too dependend on debt financing.
AXGN has a Debt to Equity ratio (0.43) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.43 | ||
| Debt/FCF | 13.85 | ||
| Altman-Z | 4.85 |
ROIC/WACC0.08
WACC8.85%
2.3 Liquidity
A Current Ratio of 4.14 indicates that AXGN has no problem at all paying its short term obligations.
With a decent Current ratio value of 4.14, AXGN is doing good in the industry, outperforming 71.43% of the companies in the same industry.
AXGN has a Quick Ratio of 2.67. This indicates that AXGN is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 2.67, AXGN is doing good in the industry, outperforming 64.55% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.14 | ||
| Quick Ratio | 2.67 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 500.00% over the past year.
The Revenue has grown by 17.17% in the past year. This is quite good.
AXGN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.92% yearly.
EPS 1Y (TTM)500%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%140%
Revenue 1Y (TTM)17.17%
Revenue growth 3Y13.72%
Revenue growth 5Y11.92%
Sales Q2Q%18.26%
3.2 Future
The Earnings Per Share is expected to grow by 50.38% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 16.23% on average over the next years. This is quite good.
EPS Next Y110.54%
EPS Next 2Y93.39%
EPS Next 3Y90.78%
EPS Next 5Y50.38%
Revenue Next Year17.82%
Revenue Next 2Y16.82%
Revenue Next 3Y15.02%
Revenue Next 5Y16.23%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 74.67 indicates a quite expensive valuation of AXGN.
AXGN's Price/Earnings ratio is a bit cheaper when compared to the industry. AXGN is cheaper than 66.14% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.89, AXGN is valued quite expensively.
A Price/Forward Earnings ratio of 36.86 indicates a quite expensive valuation of AXGN.
AXGN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. AXGN is cheaper than 70.90% of the companies in the same industry.
AXGN is valuated expensively when we compare the Price/Forward Earnings ratio to 22.99, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 74.67 | ||
| Fwd PE | 36.86 |
4.2 Price Multiples
63.49% of the companies in the same industry are more expensive than AXGN, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AXGN indicates a somewhat cheap valuation: AXGN is cheaper than 68.25% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 237.95 | ||
| EV/EBITDA | 90.83 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as AXGN's earnings are expected to grow with 90.78% in the coming years.
PEG (NY)0.68
PEG (5Y)N/A
EPS Next 2Y93.39%
EPS Next 3Y90.78%
5. Dividend
5.1 Amount
AXGN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:AXGN (10/27/2025, 1:41:09 PM)
17.92
-0.25 (-1.38%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners88.49%
Inst Owner Change0.85%
Ins Owners0.84%
Ins Owner Change-0.61%
Market Cap824.50M
Revenue(TTM)203.27M
Net Income(TTM)-4663000
Analysts84
Price Target25.37 (41.57%)
Short Float %5.65%
Short Ratio2.61
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-68.39%
Min EPS beat(2)-222.55%
Max EPS beat(2)85.77%
EPS beat(4)3
Avg EPS beat(4)275.79%
Min EPS beat(4)-222.55%
Max EPS beat(4)1125.49%
EPS beat(8)7
Avg EPS beat(8)185.94%
EPS beat(12)11
Avg EPS beat(12)146.94%
EPS beat(16)14
Avg EPS beat(16)116.93%
Revenue beat(2)1
Avg Revenue beat(2)2%
Min Revenue beat(2)-1.48%
Max Revenue beat(2)5.47%
Revenue beat(4)2
Avg Revenue beat(4)1.26%
Min Revenue beat(4)-1.48%
Max Revenue beat(4)5.47%
Revenue beat(8)5
Avg Revenue beat(8)1.38%
Revenue beat(12)7
Avg Revenue beat(12)0.53%
Revenue beat(16)7
Avg Revenue beat(16)-0.53%
PT rev (1m)0%
PT rev (3m)2.58%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.39%
EPS NY rev (1m)0%
EPS NY rev (3m)28.8%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)0.92%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)1.5%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 74.67 | ||
| Fwd PE | 36.86 | ||
| P/S | 4.06 | ||
| P/FCF | 237.95 | ||
| P/OCF | 114.72 | ||
| P/B | 7.34 | ||
| P/tB | 7.77 | ||
| EV/EBITDA | 90.83 |
EPS(TTM)0.24
EY1.34%
EPS(NY)0.49
Fwd EY2.71%
FCF(TTM)0.08
FCFY0.42%
OCF(TTM)0.16
OCFY0.87%
SpS4.42
BVpS2.44
TBVpS2.31
PEG (NY)0.68
PEG (5Y)N/A
Graham Number3.63
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.27% | ||
| ROE | -4.15% | ||
| ROCE | 0.95% | ||
| ROIC | 0.75% | ||
| ROICexc | 0.9% | ||
| ROICexgc | 0.94% | ||
| OM | 0.84% | ||
| PM (TTM) | N/A | ||
| GM | 74.27% | ||
| FCFM | 1.7% |
ROA(3y)-10.24%
ROA(5y)-11.1%
ROE(3y)-20.3%
ROE(5y)-20.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.72%
GM growth 5Y-1.5%
F-Score6
Asset Turnover0.99
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.43 | ||
| Debt/FCF | 13.85 | ||
| Debt/EBITDA | 5.16 | ||
| Cap/Depr | 49.09% | ||
| Cap/Sales | 1.83% | ||
| Interest Coverage | 0.24 | ||
| Cash Conversion | 77.33% | ||
| Profit Quality | N/A | ||
| Current Ratio | 4.14 | ||
| Quick Ratio | 2.67 | ||
| Altman-Z | 4.85 |
F-Score6
WACC8.85%
ROIC/WACC0.08
Cap/Depr(3y)337.29%
Cap/Depr(5y)669.18%
Cap/Sales(3y)9.04%
Cap/Sales(5y)13.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)500%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%140%
EPS Next Y110.54%
EPS Next 2Y93.39%
EPS Next 3Y90.78%
EPS Next 5Y50.38%
Revenue 1Y (TTM)17.17%
Revenue growth 3Y13.72%
Revenue growth 5Y11.92%
Sales Q2Q%18.26%
Revenue Next Year17.82%
Revenue Next 2Y16.82%
Revenue Next 3Y15.02%
Revenue Next 5Y16.23%
EBIT growth 1Y114.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1546.15%
EBIT Next 3Y209.77%
EBIT Next 5YN/A
FCF growth 1Y112.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y211.25%
OCF growth 3YN/A
OCF growth 5YN/A
AXOGEN INC / AXGN FAQ
What is the fundamental rating for AXGN stock?
ChartMill assigns a fundamental rating of 5 / 10 to AXGN.
What is the valuation status of AXOGEN INC (AXGN) stock?
ChartMill assigns a valuation rating of 5 / 10 to AXOGEN INC (AXGN). This can be considered as Fairly Valued.
How profitable is AXOGEN INC (AXGN) stock?
AXOGEN INC (AXGN) has a profitability rating of 4 / 10.
Can you provide the financial health for AXGN stock?
The financial health rating of AXOGEN INC (AXGN) is 6 / 10.
Can you provide the expected EPS growth for AXGN stock?
The Earnings per Share (EPS) of AXOGEN INC (AXGN) is expected to grow by 110.54% in the next year.